Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
Holding ADVM?
Track your performance easily

Adverum Biotechnologies (ADVM) Financial Statements

583 Followers

Adverum Biotechnologies Financial Overview

Adverum Biotechnologies's market cap is currently ―. The company's EPS TTM is $-7.989; its P/E ratio is -0.93; Adverum Biotechnologies is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-1.31. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit----$ 1.40M
EBIT$ -18.48M$ -24.83M$ -24.85M$ -32.87M$ -31.49M
EBITDA$ -16.66M$ -23.66M$ -23.38M$ -25.99M$ -25.16M
Net Income Common Stockholders$ -18.48M$ -24.79M$ -24.72M$ -32.82M$ -31.51M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 173.83M$ 193.33M$ 96.53M$ 117.08M$ 141.45M
Total Assets$ 253.80M$ 267.83M$ 173.01M$ 196.77M$ 241.43M
Total Debt$ 73.89M$ 74.48M$ 75.04M$ 75.52M$ 91.15M
Net Debt$ -99.94M$ -118.84M$ -21.49M$ -41.56M$ -50.30M
Total Liabilities$ 85.77M$ 85.54M$ 89.54M$ 94.06M$ 110.27M
Stockholders Equity$ 168.03M$ 182.29M$ 83.47M$ 102.71M$ 131.13M
Cash Flow-
Free Cash Flow$ -19.86M$ -23.34M$ -21.52M$ -24.41M$ -23.29M
Operating Cash Flow$ -19.84M$ -23.25M$ -21.33M$ -23.91M$ -23.25M
Investing Cash Flow$ -2.33M$ -22.03M$ -9.88M$ 18.20M$ 67.02M
Financing Cash Flow$ -116.00K$ 119.88M$ 166.00K$ -105.00K$ 8.00K
Currency in USD

Adverum Biotechnologies Earnings and Revenue History

Adverum Biotechnologies Debt to Assets

Adverum Biotechnologies Cash Flow

Adverum Biotechnologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis